Article 1 to 1 out of 1 concerning G2M Cancer Drugs AG
TopoTarget A/S Acquires G2M Cancer Drugs AG(03/03/2005) TopoTarget A/S has acquired G2M Cancer Drugs AG (G2M), the German anti-cancer therapeutics company. The move unites two companies with complementary strategies, products and research and creates a heavy weight Danish oncology company with ...
Top